Baxter International Inc. (FRA:BTL)

Market Cap	9.42B -38.9%
Revenue (ttm)	9.58B +5.7%
Net Income	-815.08M
EPS	-1.59
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.23
Dividend	0.47 (2.62%)
Ex-Dividend Date	Nov 28, 2025

Volume	n/a
Average Volume	56
Open	17.86
Previous Close	18.25
Day's Range	17.85 - 17.86
52-Week Range	14.99 - 34.84
Beta	n/a
RSI	56.26
Earnings Date	Feb 20, 2026

About Baxter International

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies;...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1931
• Employees: 37,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BTL

Financial Performance

In 2025, Baxter International's revenue was $11.24 billion, an increase of 5.72% compared to the previous year's $10.64 billion. Losses were -$957.00 million, 47.5% more than in 2024.

Financial numbers in USD